Literature DB >> 23953200

Raman spectroscopy and partial least squares analysis in discrimination of peripheral cells affected by Huntington's disease.

M Muratore1.   

Abstract

Huntington's disease (HD) is a neurodegenerative disorder caused by trinucleotide CAG (Cytosine-Adenine-Guanine) expansion on the Huntingtin gene (HTT) encoding for the Huntingtin protein (Htt). The protein has been linked in peripheral fibroblasts with dysregulation of cellular components which are part of lipid rafts in plasma membrane sub-domains. Therefore the analysis of the plasma membrane might be a useful diagnostic biomarker for the detection of the presence and possible onset of HD in readily accessible peripheral cells. Here Raman spectroscopy has been used with a chemometric approach in the form of Partial Least Square (PLS) for an initial corroboration that the plasma membrane is indeed a sub-cellular biomarker discriminator for HD identification. Observations were made in the spectral regions from 400 to 1800 cm(-1) and 2700 to 3200 cm(-1) with the former region displaying the most significant differences and peak displacement between plasma membranes extracted from HD and control fibroblast cells. The major differences in plasma membrane composition reside in sub-cellular elements putatively associated to cholesterol, phospholipids (mainly phophatidylinositol) as well as proteins containing tyrosine. These findings are indicative of the plasma membrane as an amenable biomarker for HD for further in vitro research with possible applications in vivo models.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biomarker; Chemometrics; Huntington's disease; Partial least square (PLS); Plasma membrane; Raman spectroscopy

Mesh:

Year:  2013        PMID: 23953200     DOI: 10.1016/j.aca.2013.06.012

Source DB:  PubMed          Journal:  Anal Chim Acta        ISSN: 0003-2670            Impact factor:   6.558


  7 in total

1.  Spontaneous and coherent anti-Stokes Raman spectroscopy of human gastrocnemius muscle biopsies in CH-stretching region for discrimination of peripheral artery disease.

Authors:  X Huang; S Irmak; Y F Lu; I Pipinos; G Casale; J Subbiah
Journal:  Biomed Opt Express       Date:  2015-07-07       Impact factor: 3.732

2.  Mitochondrial DNA levels in Huntington disease leukocytes and dermal fibroblasts.

Authors:  Paulina Jędrak; Magdalena Krygier; Katarzyna Tońska; Małgorzata Drozd; Magdalena Kaliszewska; Ewa Bartnik; Witold Sołtan; Emilia J Sitek; Anna Stanisławska-Sachadyn; Janusz Limon; Jarosław Sławek; Grzegorz Węgrzyn; Sylwia Barańska
Journal:  Metab Brain Dis       Date:  2017-05-16       Impact factor: 3.584

3.  Temporal blood flow changes measured by diffuse correlation tomography predict murine femoral graft healing.

Authors:  Songfeng Han; Ashley R Proctor; Jingxuan Ren; Danielle S W Benoit; Regine Choe
Journal:  PLoS One       Date:  2018-05-29       Impact factor: 3.240

4.  Definition of network types - Prediction of dough mechanical behaviour under shear by gluten microstructure.

Authors:  Isabelle Lucas; Hannes Petermeier; Thomas Becker; Mario Jekle
Journal:  Sci Rep       Date:  2019-03-18       Impact factor: 4.379

Review 5.  Altered Cholesterol Homeostasis in Huntington's Disease.

Authors:  Radhia Kacher; Coline Mounier; Jocelyne Caboche; Sandrine Betuing
Journal:  Front Aging Neurosci       Date:  2022-04-19       Impact factor: 5.750

6.  A multi-scale approach to study biochemical and biophysical aspects of resveratrol on diesel exhaust particle-human primary lung cell interaction.

Authors:  Wei Zhang; Qifei Li; Mingjie Tang; Han Zhang; Xiaoping Sun; Sige Zou; Judy L Jensen; Theodore G Liou; Anhong Zhou
Journal:  Sci Rep       Date:  2019-12-03       Impact factor: 4.379

7.  Serum Raman spectroscopy as a diagnostic tool in patients with Huntington's disease.

Authors:  Anna Huefner; Wei-Li Kuan; Sarah L Mason; Sumeet Mahajan; Roger A Barker
Journal:  Chem Sci       Date:  2019-11-14       Impact factor: 9.825

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.